G-quadruplex-binding small molecules ameliorate C9orf72 FTD/ALS pathology in vitro and in vivo

Roberto Simone, Rubika Balendra, Thomas G. Moens, Elisavet Preza, Katherine M. Wilson, Amanda Heslegrave, Nathan S. Woodling, Teresa Niccoli, Javier Gilbert-Jaramillo, Samir Abdelkarim, Emma L. Clayton, Mica Clarke, Marie Therese Konrad, Andrew J. Nicoll, Jamie S. Mitchell, Andrea Calvo, Adriano Chio, Henry Houlden, James M. Polke, Mohamed A. IsmailChad E. Stephens, Tam Vo, Abdelbasset A. Farahat, W. David Wilson, David W. Boykin, Henrik Zetterberg, Linda Partridge, Selina Wray, Gary Parkinson, Stephen Neidle, Rickie Patani, Pietro Fratta, Adrian M. Isaacs

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Intronic GGGGCC repeat expansions in C9orf72 are the most common known cause of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS), which are characterised by degeneration of cortical and motor neurons, respectively. Repeat expansions have been proposed to cause disease by both the repeat RNA forming foci that sequester RNA-binding proteins and through toxic dipeptide repeat proteins generated by repeat-associated non-ATG translation. GGGGCC repeat RNA folds into a G-quadruplex secondary structure, and we investigated whether targeting this structure is a potential therapeutic strategy. We performed a screen that identified three structurally related small molecules that specifically stabilise GGGGCC repeat G-quadruplex RNA. We investigated their effect in C9orf72 patient iPSC-derived motor and cortical neurons and show that they significantly reduce RNA foci burden and the levels of dipeptide repeat proteins. Furthermore, they also reduce dipeptide repeat proteins and improve survival in vivo, in GGGGCC repeat-expressing Drosophila. Therefore, small molecules that target GGGGCC repeat G-quadruplexes can ameliorate the two key pathologies associated with C9orf72 FTD/ALS. These data provide proof of principle that targeting GGGGCC repeat G-quadruplexes has therapeutic potential.

Original languageEnglish (US)
Pages (from-to)22-31
Number of pages10
JournalEMBO Molecular Medicine
Volume10
Issue number1
DOIs
StatePublished - Jan 2018

Fingerprint

G-Quadruplexes
Dipeptides
Pathology
Motor Neurons
RNA
Proteins
RNA-Binding Proteins
Poisons
Drosophila
Survival
Frontotemporal Dementia With Motor Neuron Disease
Therapeutics

Keywords

  • C9orf72
  • G-quadruplex
  • amyotrophic lateral sclerosis
  • frontotemporal dementia

ASJC Scopus subject areas

  • Molecular Medicine

Cite this

Simone, R., Balendra, R., Moens, T. G., Preza, E., Wilson, K. M., Heslegrave, A., ... Isaacs, A. M. (2018). G-quadruplex-binding small molecules ameliorate C9orf72 FTD/ALS pathology in vitro and in vivo. EMBO Molecular Medicine, 10(1), 22-31. https://doi.org/10.15252/emmm.201707850

G-quadruplex-binding small molecules ameliorate C9orf72 FTD/ALS pathology in vitro and in vivo. / Simone, Roberto; Balendra, Rubika; Moens, Thomas G.; Preza, Elisavet; Wilson, Katherine M.; Heslegrave, Amanda; Woodling, Nathan S.; Niccoli, Teresa; Gilbert-Jaramillo, Javier; Abdelkarim, Samir; Clayton, Emma L.; Clarke, Mica; Konrad, Marie Therese; Nicoll, Andrew J.; Mitchell, Jamie S.; Calvo, Andrea; Chio, Adriano; Houlden, Henry; Polke, James M.; Ismail, Mohamed A.; Stephens, Chad E.; Vo, Tam; Farahat, Abdelbasset A.; Wilson, W. David; Boykin, David W.; Zetterberg, Henrik; Partridge, Linda; Wray, Selina; Parkinson, Gary; Neidle, Stephen; Patani, Rickie; Fratta, Pietro; Isaacs, Adrian M.

In: EMBO Molecular Medicine, Vol. 10, No. 1, 01.2018, p. 22-31.

Research output: Contribution to journalArticle

Simone, R, Balendra, R, Moens, TG, Preza, E, Wilson, KM, Heslegrave, A, Woodling, NS, Niccoli, T, Gilbert-Jaramillo, J, Abdelkarim, S, Clayton, EL, Clarke, M, Konrad, MT, Nicoll, AJ, Mitchell, JS, Calvo, A, Chio, A, Houlden, H, Polke, JM, Ismail, MA, Stephens, CE, Vo, T, Farahat, AA, Wilson, WD, Boykin, DW, Zetterberg, H, Partridge, L, Wray, S, Parkinson, G, Neidle, S, Patani, R, Fratta, P & Isaacs, AM 2018, 'G-quadruplex-binding small molecules ameliorate C9orf72 FTD/ALS pathology in vitro and in vivo', EMBO Molecular Medicine, vol. 10, no. 1, pp. 22-31. https://doi.org/10.15252/emmm.201707850
Simone, Roberto ; Balendra, Rubika ; Moens, Thomas G. ; Preza, Elisavet ; Wilson, Katherine M. ; Heslegrave, Amanda ; Woodling, Nathan S. ; Niccoli, Teresa ; Gilbert-Jaramillo, Javier ; Abdelkarim, Samir ; Clayton, Emma L. ; Clarke, Mica ; Konrad, Marie Therese ; Nicoll, Andrew J. ; Mitchell, Jamie S. ; Calvo, Andrea ; Chio, Adriano ; Houlden, Henry ; Polke, James M. ; Ismail, Mohamed A. ; Stephens, Chad E. ; Vo, Tam ; Farahat, Abdelbasset A. ; Wilson, W. David ; Boykin, David W. ; Zetterberg, Henrik ; Partridge, Linda ; Wray, Selina ; Parkinson, Gary ; Neidle, Stephen ; Patani, Rickie ; Fratta, Pietro ; Isaacs, Adrian M. / G-quadruplex-binding small molecules ameliorate C9orf72 FTD/ALS pathology in vitro and in vivo. In: EMBO Molecular Medicine. 2018 ; Vol. 10, No. 1. pp. 22-31.
@article{79e0fac9a80d440899096cb390e40a19,
title = "G-quadruplex-binding small molecules ameliorate C9orf72 FTD/ALS pathology in vitro and in vivo",
abstract = "Intronic GGGGCC repeat expansions in C9orf72 are the most common known cause of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS), which are characterised by degeneration of cortical and motor neurons, respectively. Repeat expansions have been proposed to cause disease by both the repeat RNA forming foci that sequester RNA-binding proteins and through toxic dipeptide repeat proteins generated by repeat-associated non-ATG translation. GGGGCC repeat RNA folds into a G-quadruplex secondary structure, and we investigated whether targeting this structure is a potential therapeutic strategy. We performed a screen that identified three structurally related small molecules that specifically stabilise GGGGCC repeat G-quadruplex RNA. We investigated their effect in C9orf72 patient iPSC-derived motor and cortical neurons and show that they significantly reduce RNA foci burden and the levels of dipeptide repeat proteins. Furthermore, they also reduce dipeptide repeat proteins and improve survival in vivo, in GGGGCC repeat-expressing Drosophila. Therefore, small molecules that target GGGGCC repeat G-quadruplexes can ameliorate the two key pathologies associated with C9orf72 FTD/ALS. These data provide proof of principle that targeting GGGGCC repeat G-quadruplexes has therapeutic potential.",
keywords = "C9orf72, G-quadruplex, amyotrophic lateral sclerosis, frontotemporal dementia",
author = "Roberto Simone and Rubika Balendra and Moens, {Thomas G.} and Elisavet Preza and Wilson, {Katherine M.} and Amanda Heslegrave and Woodling, {Nathan S.} and Teresa Niccoli and Javier Gilbert-Jaramillo and Samir Abdelkarim and Clayton, {Emma L.} and Mica Clarke and Konrad, {Marie Therese} and Nicoll, {Andrew J.} and Mitchell, {Jamie S.} and Andrea Calvo and Adriano Chio and Henry Houlden and Polke, {James M.} and Ismail, {Mohamed A.} and Stephens, {Chad E.} and Tam Vo and Farahat, {Abdelbasset A.} and Wilson, {W. David} and Boykin, {David W.} and Henrik Zetterberg and Linda Partridge and Selina Wray and Gary Parkinson and Stephen Neidle and Rickie Patani and Pietro Fratta and Isaacs, {Adrian M.}",
year = "2018",
month = "1",
doi = "10.15252/emmm.201707850",
language = "English (US)",
volume = "10",
pages = "22--31",
journal = "EMBO Molecular Medicine",
issn = "1757-4676",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - G-quadruplex-binding small molecules ameliorate C9orf72 FTD/ALS pathology in vitro and in vivo

AU - Simone, Roberto

AU - Balendra, Rubika

AU - Moens, Thomas G.

AU - Preza, Elisavet

AU - Wilson, Katherine M.

AU - Heslegrave, Amanda

AU - Woodling, Nathan S.

AU - Niccoli, Teresa

AU - Gilbert-Jaramillo, Javier

AU - Abdelkarim, Samir

AU - Clayton, Emma L.

AU - Clarke, Mica

AU - Konrad, Marie Therese

AU - Nicoll, Andrew J.

AU - Mitchell, Jamie S.

AU - Calvo, Andrea

AU - Chio, Adriano

AU - Houlden, Henry

AU - Polke, James M.

AU - Ismail, Mohamed A.

AU - Stephens, Chad E.

AU - Vo, Tam

AU - Farahat, Abdelbasset A.

AU - Wilson, W. David

AU - Boykin, David W.

AU - Zetterberg, Henrik

AU - Partridge, Linda

AU - Wray, Selina

AU - Parkinson, Gary

AU - Neidle, Stephen

AU - Patani, Rickie

AU - Fratta, Pietro

AU - Isaacs, Adrian M.

PY - 2018/1

Y1 - 2018/1

N2 - Intronic GGGGCC repeat expansions in C9orf72 are the most common known cause of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS), which are characterised by degeneration of cortical and motor neurons, respectively. Repeat expansions have been proposed to cause disease by both the repeat RNA forming foci that sequester RNA-binding proteins and through toxic dipeptide repeat proteins generated by repeat-associated non-ATG translation. GGGGCC repeat RNA folds into a G-quadruplex secondary structure, and we investigated whether targeting this structure is a potential therapeutic strategy. We performed a screen that identified three structurally related small molecules that specifically stabilise GGGGCC repeat G-quadruplex RNA. We investigated their effect in C9orf72 patient iPSC-derived motor and cortical neurons and show that they significantly reduce RNA foci burden and the levels of dipeptide repeat proteins. Furthermore, they also reduce dipeptide repeat proteins and improve survival in vivo, in GGGGCC repeat-expressing Drosophila. Therefore, small molecules that target GGGGCC repeat G-quadruplexes can ameliorate the two key pathologies associated with C9orf72 FTD/ALS. These data provide proof of principle that targeting GGGGCC repeat G-quadruplexes has therapeutic potential.

AB - Intronic GGGGCC repeat expansions in C9orf72 are the most common known cause of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS), which are characterised by degeneration of cortical and motor neurons, respectively. Repeat expansions have been proposed to cause disease by both the repeat RNA forming foci that sequester RNA-binding proteins and through toxic dipeptide repeat proteins generated by repeat-associated non-ATG translation. GGGGCC repeat RNA folds into a G-quadruplex secondary structure, and we investigated whether targeting this structure is a potential therapeutic strategy. We performed a screen that identified three structurally related small molecules that specifically stabilise GGGGCC repeat G-quadruplex RNA. We investigated their effect in C9orf72 patient iPSC-derived motor and cortical neurons and show that they significantly reduce RNA foci burden and the levels of dipeptide repeat proteins. Furthermore, they also reduce dipeptide repeat proteins and improve survival in vivo, in GGGGCC repeat-expressing Drosophila. Therefore, small molecules that target GGGGCC repeat G-quadruplexes can ameliorate the two key pathologies associated with C9orf72 FTD/ALS. These data provide proof of principle that targeting GGGGCC repeat G-quadruplexes has therapeutic potential.

KW - C9orf72

KW - G-quadruplex

KW - amyotrophic lateral sclerosis

KW - frontotemporal dementia

UR - http://www.scopus.com/inward/record.url?scp=85040286038&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040286038&partnerID=8YFLogxK

U2 - 10.15252/emmm.201707850

DO - 10.15252/emmm.201707850

M3 - Article

C2 - 29113975

AN - SCOPUS:85040286038

VL - 10

SP - 22

EP - 31

JO - EMBO Molecular Medicine

JF - EMBO Molecular Medicine

SN - 1757-4676

IS - 1

ER -